Lytix Biopharma AS
F:6BG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lytix Biopharma AS
F:6BG
|
NO |
|
Z
|
Zooplus AG
F:ZO1
|
DE |
Wall Street
Price Targets
6BG Price Targets Summary
Lytix Biopharma AS
According to Wall Street analysts, the average 1-year price target for 6BG is 1.15 EUR with a low forecast of 1.14 EUR and a high forecast of 1.19 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 6BG's stock price target?
Price Target
1.15
EUR
According to Wall Street analysts, the average 1-year price target for 6BG is 1.15 EUR with a low forecast of 1.14 EUR and a high forecast of 1.19 EUR.
What is Lytix Biopharma AS's Revenue forecast?
Projected CAGR
55%
For the last 6 years the compound annual growth rate for Lytix Biopharma AS's revenue is 79%. The projected CAGR for the next 2 years is 55%.
